Full metadata record
DC FieldValueLanguage
dc.creatorSalinas-Alaman, A. (Ángel)-
dc.creatorGarcia-Layana, A. (Alfredo)-
dc.creatorSanchez-Carpintero, L.M. (Luis M.)-
dc.creatorBelzunce, A. (Arnaldo)-
dc.date.accessioned2012-10-24T08:48:22Z-
dc.date.available2012-10-24T08:48:22Z-
dc.date.issued2005-
dc.identifier.citationSalinas-Alaman A, Garcia-Layana A, Sadaba-Echarri LM, Belzunce-Manterola A. Triamcinolona intravítrea en el tratamiento de la oclusión de rama venosa retiniana. Arch Soc Esp Oftalmol 2005 Aug;80(8):463-465.es_ES
dc.identifier.issn0365-6691-
dc.identifier.urihttps://hdl.handle.net/10171/23478-
dc.description.abstractClinical cases: Five eyes with branch retinal vein occlusion (BRVO) were treated with intravitreal injection of 4 mg of triamcinolone. Four cases showed good visual acuity and macular thickness evolution after one dose. The remaining one case suffered a relapse three months later. Therefore a second injection was performed in that case. Discussion: Several treatments have been suggested to manage macular edema in BRVO. Intravitreal triamcinolone may be a therapeutic option to increase visual acuity and decrease macular thickness in patients with macular edema secondary to BRVOes_ES
dc.language.isospaes_ES
dc.publisherElsevier Españaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectBranch retinal vein occlusiones_ES
dc.subjectTriamcinolonees_ES
dc.subjectMacular edemaes_ES
dc.titleTriamcinolona intravítrea en el tratamiento de la oclusión de rama venosa retinianaes_ES
dc.title.alternativeBranch retinal vein occlusion treated by intravitreal triamcinolonees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES
dc.identifier.doihttp://dx.doi.org/10.4321/S0365-66912005000800007es_ES

Files in This Item:
Thumbnail
File
Arch Soc Esp Oftalmol 2005.463.pdf
Description
Size
98.52 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.